Abstract
Salmonella enterica is a Gram-negative intracellular bacterial pathogen which causes salmonellosis in humans and animals. During the past several decades, extensive studies have shown that the attenuated Salmonella vaccine vector is an optimal vehicle for delivering passenger antigens to mucosal sites to induce humoral, cellular, and mucosal immunity. This immunity leads to protection against challenges with the wild-type pathogens from which the passenger antigens were derived. A myriad of studies have demonstrated that using attenuated Salmonella vaccines for recombinant multivalent vaccine construction has multiple advantages. In this review, we summarize these advantages and further evaluate the Salmonella-based vaccines against five bacterial diseases. Four of these are Gram-negative pathogens— Escherichia coli, Helicobacter pylori, Shigella dysenteriae, and Yersinia pestis—and one is a mycobacterial pathogen, Mycobacterium tuberculosis. Apart from H. pylori, the Salmonella-based vaccines against the other four pathogens exhibit excellent performance in safety, immunogenicity, and protection. These properties qualify them to be as a new generation of vaccines for preventing infections from bacterial pathogens.
Keywords: Escherichia coli, Helicobacter pylori, Mycobacterium tuberculosis, passenger antigen, recombinant vaccine, Salmonella vaccine vector, Shigella dysenteriae, Yersinia pestis
Current Pharmaceutical Biotechnology
Title:Recombinant Salmonella Vaccination Technology and Its Application to Human Bacterial Pathogens
Volume: 14 Issue: 2
Author(s): Song Zhang, Nancy Walters, Ling Cao, Amanda Robison and Xinghong Yang
Affiliation:
Keywords: Escherichia coli, Helicobacter pylori, Mycobacterium tuberculosis, passenger antigen, recombinant vaccine, Salmonella vaccine vector, Shigella dysenteriae, Yersinia pestis
Abstract: Salmonella enterica is a Gram-negative intracellular bacterial pathogen which causes salmonellosis in humans and animals. During the past several decades, extensive studies have shown that the attenuated Salmonella vaccine vector is an optimal vehicle for delivering passenger antigens to mucosal sites to induce humoral, cellular, and mucosal immunity. This immunity leads to protection against challenges with the wild-type pathogens from which the passenger antigens were derived. A myriad of studies have demonstrated that using attenuated Salmonella vaccines for recombinant multivalent vaccine construction has multiple advantages. In this review, we summarize these advantages and further evaluate the Salmonella-based vaccines against five bacterial diseases. Four of these are Gram-negative pathogens— Escherichia coli, Helicobacter pylori, Shigella dysenteriae, and Yersinia pestis—and one is a mycobacterial pathogen, Mycobacterium tuberculosis. Apart from H. pylori, the Salmonella-based vaccines against the other four pathogens exhibit excellent performance in safety, immunogenicity, and protection. These properties qualify them to be as a new generation of vaccines for preventing infections from bacterial pathogens.
Export Options
About this article
Cite this article as:
Zhang Song, Walters Nancy, Cao Ling, Robison Amanda and Yang Xinghong, Recombinant Salmonella Vaccination Technology and Its Application to Human Bacterial Pathogens, Current Pharmaceutical Biotechnology 2013; 14 (2) . https://dx.doi.org/10.2174/1389201011314020011
DOI https://dx.doi.org/10.2174/1389201011314020011 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Signal Transduction and Photodynamic Therapy
Current Signal Transduction Therapy Proteomics and Protein Analyses of Ovine and Caprine Body Fluids: Current Studies and Future Promises
Current Protein & Peptide Science The Role of JNK Signalling in Responses to Oxidative DNA Damage
Current Drug Targets Metallothionein as a Scavenger of Free Radicals - New Cardioprotective Therapeutic Agent or Initiator of Tumor Chemoresistance?
Current Drug Targets Cancer and Phase II Drug-Metabolizing Enzymes
Current Drug Metabolism Anti-Inflammatory Treatments for Chronic Diseases: A Review
Inflammation & Allergy - Drug Targets (Discontinued) A New Approach to Locate the Gallbladder from Ultrasound Image Using Intensity Stretching and SOM-based Color Quantization
Current Medical Imaging The Pim Kinases: New Targets for Drug Development
Current Drug Targets Clinical Application of Ghrelin
Current Pharmaceutical Design Regulatory T Cells: Major Players in the Tumor Microenvironment
Current Pharmaceutical Design Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Emerging Role of Mucins in Epithelial to Mesenchymal Transition
Current Cancer Drug Targets Metabolic Pathways of Ochratoxin A
Current Drug Metabolism Integration of Pharmacogenomics and Pharmacometrics to Support Drug Development, Regulatory and Therapeutic Decisions
Current Pharmacogenomics and Personalized Medicine Are Selenoproteins Important for the Cancer Protective Effects of Selenium?
Current Nutrition & Food Science Glucagon and Glucagon-Like Peptide Receptors as Drug Targets
Current Pharmaceutical Design Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Current Medicinal Chemistry Matrine: Bioactivities and Structural Modifications
Current Topics in Medicinal Chemistry Medicinal Research Progress of Natural Coumarin and its Derivatives
The Natural Products Journal MicroRNAs in Lymphoma: Regulatory Role and Biomarker Potential
Current Genomics